Edition:
United Kingdom

Capricor Therapeutics Inc (CAPR.OQ)

CAPR.OQ on NASDAQ Stock Exchange Capital Market

0.63USD
16 Jan 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.63
Open
$0.69
Day's High
$0.69
Day's Low
$0.63
Volume
2,773
Avg. Vol
26,668
52-wk High
$2.29
52-wk Low
$0.31

Select another date:

Wed, Dec 26 2018

U.S. drug developer Capricor places Duchenne drug trial on hold

Capricor Therapeutics Inc said on Wednesday it had put on hold a clinical trial of its drug to treat Duchenne muscular dystrophy (DMD), a muscle-wasting disorder, citing a safety review.

UPDATE 1-U.S. drug developer Capricor places Duchenne drug trial on hold

Dec 26 Capricor Therapeutics Inc said on Wednesday it had put on hold a clinical trial of its drug to treat Duchenne muscular dystrophy (DMD), a muscle-wasting disorder, citing a safety review.

Capricor places Duchenne drug trial on hold

Dec 26 Capricor Therapeutics Inc said on Wednesday it had put on hold a clinical trial of its drug to treat Duchenne muscular dystrophy, a muscle-wasting disorder.

Select another date: